About colorectalcc

This author has not yet filled in any details.
So far colorectalcc has created 283 blog entries.

Does colon tumour location play a role in metastasis and survival?

October 2023 Colorectal cancer, the third most common cancer worldwide, can present differently depending on where it develops within the colon, which can have a significant impact on the progression of the disease, treatment response, and patient outcomes. This article explores new research studying these differences and their implications for ...

By |October 30, 2023|Blog|Comments Off on Does colon tumour location play a role in metastasis and survival?

Gut Microbiome Variations and Colorectal Cancer Risk

October 2023 Recent findings presented at United European Gastroenterology Week demonstrated that patients with precancerous colorectal tumours showed significant variations in their gut microbiome. The connection between the gut microbiome - the totality of microorganisms such as bacteria, fungi, and viruses that colonize the intestines - and precancerous tumours has ...

By |October 30, 2023|Blog|Comments Off on Gut Microbiome Variations and Colorectal Cancer Risk

Impact of Cancer on the Family: Coping and Supporting Each Other Through a Colorectal Cancer Diagnosis

A colorectal cancer diagnosis is life-changing and affects not only the patient, but also the entire family. Having a solid support system is important throughout the cancer process, as it can be extremely difficult at times. Family support and connection can make a significant difference in how a patient copes ...

By |October 18, 2023|Blog|Comments Off on Impact of Cancer on the Family: Coping and Supporting Each Other Through a Colorectal Cancer Diagnosis

Exercise linked to lower mortality risk across different cancer types

September 2023 After a cancer diagnosis, the impact of exercise on cancer and non-cancer mortality among survivors, and whether the benefit of exercise differs depending on the cancer type, remains unclear. A recent study found that regular exercise can significantly reduce a cancer survivor’s risk of dying from cancer and ...

By |September 26, 2023|Blog|Comments Off on Exercise linked to lower mortality risk across different cancer types

Predicting recurrence in CRC using post-operative circulating tumour DNA

September 2023 Circulating tumour DNA (ctDNA) refers to the fragments of genetic material (DNA) from tumours that can be detected in the blood. A ctDNA negative result means that no remaining cancer was detected by the test. While this does not guarantee that the cancer will not come back, studies ...

By |September 26, 2023|Blog|Comments Off on Predicting recurrence in CRC using post-operative circulating tumour DNA

Shane’s story

I was diagnosed in April 2022 with stage 3c rectal cancer at 34 with no family history and only some minor symptoms.  At first, I attempted to deal with the symptoms myself, assuming I had hemorrhoids, and put off seeing my doctor out of embarrassment.  I never thought for a ...

By |September 26, 2023|Story, screenat45 Story|Comments Off on Shane’s story

Coping with Metastatic Cancer

Learning that you have metastatic cancer can be a physically and emotionally life-changing moment. Many emotions may arise, including uncertainty, anger, confusion, sadness, fear, and many others. The plans you once had may be up in the air, and you may not be sure what will happen next. You may ...

By |August 29, 2023|Blog|Comments Off on Coping with Metastatic Cancer

The FDA approves Lonsurf plus bevacizumab for metastatic colorectal cancer

August 2023 The US Food and Drug Administration (FDA) has approved the combination therapy of trifluridine/tipiracil (Lonsurf) and bevacizumab for the treatment of adults with metastatic colorectal cancer (mCRC) who have received previous treatment with 5-FU-, oxaliplatin- and irinotecan-based chemotherapy (such as FOLFOX and FOLFIRI), an anti-VEGF targeted therapy (such ...

By |August 29, 2023|Blog, Clinical Trials|Comments Off on The FDA approves Lonsurf plus bevacizumab for metastatic colorectal cancer

Liver transplant improves survival for certain patients with colorectal cancer liver metastases

August 2023 A recent study demonstrated that a liver transplant provided a 10-year overall survival (OS) rate of more than 80% for selected patients with colorectal cancer (CRC) and nonresectable liver metastases. Non-resectable liver metastases: liver metastases that cannot be safely removed with surgery, for reasons such as the metastatic ...

By |August 29, 2023|Blog|Comments Off on Liver transplant improves survival for certain patients with colorectal cancer liver metastases

Lisa’s story

If you’re here reading this, you probably already have your diagnosis. Maybe you’re at the beginning, maybe you have finished your treatment or maybe you’re just moving through the uncertain process. That’s where I am. A woman diagnosed with stage IV colon cancer in the spring of 2022 at age ...

By |August 29, 2023|Story|Comments Off on Lisa’s story
Go to Top